Undifferentiated connective tissue disease with various pigmentary patterns: a study of three patients
Bukhari, I.A.
Journal of Drugs in Dermatology Jdd 3(5): 560-562
2004
ISSN/ISBN: 1545-9616 PMID: 15552610 Document Number: 10334
Undifferentiated connective tissue disease (UCTD) is a condition characterized by the presence of clinical manifestations suggestive of a connective tissue disease and at least one non-organ specific autoantibody. In this report I am presenting three types of cutaneous pigmentary changes are presented in three patients which were the clue to the diagnosis of UCTD.
Document emailed within 1 workday
Related Documents
Pepmueller, P.H. 2016: Undifferentiated Connective Tissue Disease, Mixed Connective Tissue Disease, and Overlap Syndromes in Rheumatology Missouri Medicine 113(2): 136-140Conti, V.; Leone, M.C.; Casato, M.; Nicoli, M.; Granata, G.; Carlesimo, M. 2015: High prevalence of gluten sensitivity in a cohort of patients with undifferentiated connective tissue disease European Annals of Allergy and Clinical Immunology 47(2): 54-57
Kumánovics, G.; Zibotics, H.; Juhász, E.; Komócsi, A.; Czirják, L. 2001: Subclinical pulmonary involvement assessed by bronchoalveolar lavage in patients with early undifferentiated connective tissue disease Clinical and Experimental Rheumatology 19(5): 551-559
Louthrenoo, W.; Boonyaratavej, S.; Sittiwangkul, R.; Sukitawut, W. 1998: Anti Ro/SSA positive undifferentiated connective tissue disease in a mother with a newborn with complete congenital heart block: a case report Journal of the Medical Association of Thailand 81(8): 633-636
Brandt, J.; Maier, T.; Rudwaleit, M.; Kühl, U.; Hiepe, F.; Sieper, J.; Braun, J. 2002: Co-occurrence of spondyloarthropathy and connective tissue disease: development of Sjögren's syndrome and mixed connective tissue disease (MCTD) in a patient with ankylosing spondylitis Clinical and Experimental Rheumatology 20(1): 80-84
Pizova, N.V.; Dmitriev, A.N.; Druzhinin, D.S.; Chizhov, P.A.; Tabakov, V. 2012: The syndrome of undifferentiated dysplasia of the connective tissue Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 112(6): 4-7
Alarcón-Segovia, D.; Cardiel, M.H. 1989: Comparison between 3 diagnostic criteria for mixed connective tissue disease. Study of 593 patients Journal of Rheumatology 16(3): 328-334
Fishbein, E.; Ramos-Niembro, F.; Alarcon-Segovia, D. 1978: Free serum ribonucleoprotein in mixed connective tissue disease and other connective tissue diseases Journal of Rheumatology 5(4): 384-390
Narula, N.; Narula, T.; Mira-Avendano, I.; Wang, B.; Abril, A. 2018: Interstitial lung disease in patients with mixed connective tissue disease: pilot study on predictors of lung involvement Clinical and Experimental Rheumatology 36(4): 648-651
Kotajima, L.; Aotsuka, S.; Sumiya, M.; Yokohari, R.; Tojo, T.; Kasukawa, R. 1996: Clinical features of patients with juvenile onset mixed connective tissue disease: analysis of data collected in a nationwide collaborative study in Japan Journal of Rheumatology 23(6): 1088-1094
Paolino, S.; Ferrari, G.; Pizzorni, C.; Patanè, M.; Smith, V.; Cutolo, M.; Sulli, A. 2019: Long-term follow-up of nailfold videocapillaroscopic microvascular parameters in mixed connective tissue disease versus systemic sclerosis patients: a retrospective cohort study Clinical and Experimental Rheumatology 37 Suppl. 119(4): 102-107
Houtman, P.M.; Kallenberg, C.G.; Limburg, P.C.; Huitema, M.G.; van Rijswijk, M.H.; The, T.H. 1985: Quantitation of antibodies to nucleoribonucleoprotein by ELISA: relation between antibody levels and disease activity in patients with connective tissue disease Clinical and Experimental Immunology 62(3): 696-704
Luciak, M.; Petelenz, T.; Adamczyk, R.; Słomińska-Petelenz, T.; Drazkiewicz, U.; Zuk-Popiołek, I. 1989: Histopathological studies of connective tissue in patients with acquired valvular heart disease Materia Medica Polona. Polish Journal of Medicine and Pharmacy 21(4): 292-296
Vandergheynst, F.; Ocmant, A.; Sordet, C.; Humbel, R.L.; Goetz, J.; Roufosse, F.; Cogan, E.; Sibilia, J. 2006: Anti-pm/scl antibodies in connective tissue disease: Clinical and biological assessment of 14 patients Clinical and Experimental Rheumatology 24(2): 129-133
Hrncír, Z.; Bradna, P.; Nozicková, H.; Tichý, M. 1991: Long-term study of diffuse connective tissue disease after methylprednisolone pulsed therapy Vnitrni Lekarstvi 37(1): 63-72
DeSchryver-Kecskemeti, K.; Clouse, R.E. 1989: Perineural and intraneural inflammatory infiltrates in the intestines of patients with systemic connective-tissue disease Archives of Pathology and Laboratory Medicine 113(4): 394-398
Nabeshima, K.; Kataoka, H.; Koita, H.; Murayama, T.; Koono, M. 1988: A new long-term in vitro invasion assay using fibrous connective tissue matrices maintaining architectural characteristics of connective tissue Invasion and Metastasis 8(5): 301-316
Da Costa, J.; Gomes, J.A.; Espirito Santo, J.; Queirós, M. 1987: Inefficacy of diltiazem in the treatment of Raynaud's phenomenon with associated connective tissue disease: a double blind placebo controlled study Journal of Rheumatology 14(4): 858-859
Castor, C.W. 1973: Connective tissue activation. V. the flux of connective tissue activating peptide during acute inflammation Journal of Laboratory and Clinical Medicine 81(1): 95-104
Ogawa, N.; Shimoyama, K.; Kawabata, H.; Masaki, Y.; Wano, Y.; Sugai, S. 2003: Clinical significance of serum KL-6 and SP-D for the diagnosis and treatment of interstitial lung disease in patients with diffuse connective tissue disorders Ryumachi 43(1): 19-28